Tumors Responsive to Autophagy-Inhibition: Identification and Biomarkers

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Current cancer treatments face limitations due to their "one-size-fits-all" approach.
• Personalized medicine requires identifying predictive biomarkers and cancer-specific vulnerabilities.
• Autophagy, a cellular recycling process, is essential for maintaining homeostasis.

Purpose of the Study:

• To review tumor subtypes with heightened dependence on autophagy for survival.
• To identify autophagy as an exploitable vulnerability in cancer therapy.
• To highlight factors that can be leveraged for autophagy-targeted interventions.

Main Methods:

• Literature review of scientific articles on autophagy and cancer.
• Analysis of tumor (sub)types exhibiting increased reliance on autophagy.
• Inventory of microenvironmental factors, genetic alterations, and therapies relevant to autophagy inhibition.

Main Results:

• Certain cancer types show elevated dependence on autophagy for survival.
• Autophagy inhibition presents a potential therapeutic strategy for these tumors.
• Microenvironmental factors, genetic changes, and existing therapies can be exploited for autophagy targeting.

Conclusions:

• Targeting autophagy is a viable strategy to enhance conventional anti-tumor therapies.
• Understanding tumor-specific dependencies on autophagy is key for personalized treatment.
• Autophagy inhibition offers a promising avenue for improving cancer treatment efficacy.